Discover a wealth of knowledge at Westonci.ca, where experts provide answers to your most pressing questions. Our platform offers a seamless experience for finding reliable answers from a network of experienced professionals. Connect with a community of professionals ready to help you find accurate solutions to your questions quickly and efficiently.
Sagot :
Autologous cytokine-induced killer cell transfusion in combination with gemcitabine plus cisplatin regimen chemotherapy for metastatic nasopharyngeal carcinoma.
- In this study, we assess the effectiveness of autologous cytokine-induced killer cells (CIK) transfusion combined with gemcitabine and cisplatin (GC) chemotherapy for the treatment of nasopharyngeal cancer in patients with distant metastases following radiotherapy.
- As a result, our study suggested that patients with postradiotherapy distant nasopharyngeal carcinoma metastases may benefit better from CIK cell transfusion therapy combined with GC chemotherapy.
- While the 30 patients in the GC group only received GC chemotherapy, the 30 patients in the GC+CIK group also received an adoptive autologous CIK cell transfusion.
To learn more about chemotherapy.
brainly.com/question/12147641
#SPJ4
We hope this information was helpful. Feel free to return anytime for more answers to your questions and concerns. We hope this was helpful. Please come back whenever you need more information or answers to your queries. Thank you for choosing Westonci.ca as your information source. We look forward to your next visit.